2 completed, 1 active not recruiting, 1 recruiting. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
Follow Farxiga: new trials by email Literature Review of Farxiga trials Research Report on Farxiga
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HbA1c Variability in Type II Diabetes Metformin, Gliclazide, Sitagliptin - Diabetes Mellitus Type 2 | Not applicable | Active not recruiting | Weill Cornell Medical College in Qatar | 150 | 2016-11-01 | 2025-07-20 |
| An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes Exenatide/Exenatide extended release, Dapagliflozin, Placebo - Evaluate Ketogenic Stress | Not applicable | Completed | University at Buffalo | 70 | 2016-11-01 | 2024-02-29 |
| ESR-15-11293 - Saxa/Dapa, Safety and Efficacy Study Saxagliptin, Dapagliflozin, Placebo - Diabetes Mellitus, Type 2 | Not applicable | Completed | The University of Texas Health Science Center at San Antonio | 56 | 2016-01-01 | 2019-08-14 |
| Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) Dapagliflozin, Saxagliptin, Pioglitazone - Diabetes Mellitus, Type 2, Impaired Glucose Tolerance (IGT) | Not applicable | Recruiting | The University of Texas Health Science Center at San Antonio | 700 | 2014-01-01 | 2026-09-22 |
Diabetes Mellitus, Type 2 (3) · Diabetes Mellitus, Type 1 (1) · Glucose Intolerance (1) · Ketosis (1)
The University of Texas Health Science Center at San Antonio (2) · University at Buffalo (1) · Weill Cornell Medical College in Qatar (1)
United States (3) · Qatar (1)
Ralph A DeFronzo, MD (2) · Eugenio Cersosimo, MD (1) · Rayaz Malik, MD PhD (1)
R01DK024092 (1)